http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-9812010-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C229-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 1998-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d423b68b5a47988aaca6f15ba6fc5c44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_614845d80fa398bb5d3e73faf707b05b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90ed9b58de8fdaa97b937dbcceb0831b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2618f216b9ef05c191474de7799019b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12a82301da1e8d55c1dd06272147e9a9
publicationDate 2000-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-9812010-A
titleOfInvention Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
abstract Invention Patent: <B> "CERTAIN 5-ALKYL-2-ARYLAMINOPHENYLACETIC AND DERIVED ACIDS" <D>. Compounds of formula I are described in which R is methyl or ethyl; R ~ 1 ~ is chlorine or fluorine; R ~ 2 ~ is hydrogen or fluorine; R ~ 3 ~ is hydrogen, fluorine, chlorine, methyl, ethyl, methoxy, ethoxy or hydroxy; R ~ 4 ~ is hydrogen or fluorine; and R ~ 5 ~ is chlorine, fluorine, trifluoromethyl or methyl; the pharmaceutically acceptable salts thereof; and the pharmaceutically acceptable prodrug esters thereof; as selective inhibitors of COX-2 cyclooxygenase.
priorityDate 1997-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516

Total number of triples: 39.